Long-term Ketamine Treatment for Depression May Reduce Risk of Relapse

A first-of-its-kind review suggests that regular treatments are effective at reducing risk of relapse, though researchers say more study is needed.

MAPS Prepares For Trial in Wrongful Death Lawsuit

The MAPS nonprofit faces a jury trial next week to address a lawsuit brought by the family of a woman who died after being at the Zendo care space at a music festival in 2017.

Remembering Ann Shulgin and What She Taught Us About the Shadow 

The legendary pioneer of psychedelic-assisted therapy leaves behind a legacy of wisdom for healers and explorers of the subconscious.

Psychedelic Therapy Training Programs Expand To Meet Demand

As the need for psychedelic therapists expands, more training programs emerge to meet the needs of patients.

Survey Finds Those Who Take Psilocybin Less Likely to Abuse Opioids

Researchers are exploring possible causal links between use of magic mushrooms and opioid dependency.

Researchers May Have Created LSD-Analogs that Treat Depression Without the Trip

If proven safe and effective in humans, such “no-trip psychedelics” could potentially deliver relief from depression and other mental health conditions to millions more people than could traditional psychedelics.

Researchers Ask if Psychedelics Inevitably Turn You into a Mystic

After psychedelics, people are more likely to have “non-physicalist” beliefs, according to a new study.

Fireside Project’s New Equity Initiative Expands Psychedelic Support Services

Since launching last year, Fireside Project has supported more than 1,700 people on its Psychedelic Peer Support Line, and now the organization is promoting more inclusion and diversity.

Ketamine Could Treat Alcohol Use Disorder, Study Shows

Ketamine coupled with psychotherapy shows promise as a treatment option for alcohol use disorder in a Phase 2 clinical trial, adding momentum to the use of psychedelics for treat ing substance abuse.

Effects of Psilocybin-Assisted Therapy for Depression Shown to Last for a Year

The Johns Hopkins study is the longest follow-up to date and indicates that therapy protocols and other factors are important to positive treatment outcomes.